For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Adult: PO- Depression- Initial:50-75 mg/day; up to 150 mg/day if needed. Max: 300 mg/day in severe cases. Neuropathic pain- Initial: 10-25 mg/day at night, up to 75 mg/day if needed. Migraine ...

Amitriptyline is a prescription drug available as a tablet in several strengths. It’s approved for use to treat depression but is also often prescribed for several other conditions like pain, ...

Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets after testing identified levels of N-nitrosodimethylamine (NDMA) above what is considered acceptable if the drug were to be taken ...

Chlordiazepoxide, amitriptyline HCl; 5mg/12.5mg, 10mg/25mg; tabs. Both components of chlordiazepoxide and amitriptyline HCl tablets exert their action in the central nervous system. Extensive studies ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.

It has been proposed that antidepressants have neuroprotective effects on hippocampal neurons. To further test this hypothesis, brain-derived neurotrophic factor (BDNF), B cell lymphoma protein-2 (Bcl ...

Amitriptyline and placebo are equally effective in the management of pain-predominant functional gastrointestinal disorders (FGIDs) in children, according to the results of a new multicenter study ...

UPDATE: April 29, 2021 – Second lot recalled due to presence of nitrosamine impurity Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after ...

Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after testing identified NDMA, a nitrosamine impurity, above the acceptable limit. The affected ...